Guidant's DISCOVERY II pacemaker gets US approval:
This article was originally published in Clinica
Guidant has received US FDA approval for its DISCOVERY II single sensor pacemaker. The device will complement another of the company's sensor products, the PULSAR MAX pacemaker. The DISCOVERY II is designed to simplify clinician interaction with a pacemaker, enabling physicians to easily and efficiently perform comprehensive tests and follow-up operations. The device also provides a concise report that presents information needed for patient management.
You may also be interested in...
Complaint lists host of problems with implementation of the rule that allows states to sponsor programs to import certain prescription drugs from Canada; at least six states have enacted legislation to sponsor these programs.
Target guests in selected locations will be able to shop a curated Ulta Beauty section in the second half of 2021. The partnership could attract new clientele to Target stores and give Ulta a boost following nationwide store closures this year due to COVID.
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.